Trials (Humanitas Research Hospital): Revision history

15 December 2025

• curprev 11:5011:50, 15 December 2025‎ Francine talk contribs‎ 92,665 bytes +218‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 92,447 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 00:2300:23, 4 December 2025‎ Larysse talk contribs‎ 90,746 bytes +47‎ No edit summary undo

2 December 2025

• curprev 13:5813:58, 2 December 2025‎ Lucas talk contribs‎ m 90,699 bytes +90‎ Update categories. undo

4 December 2023

• curprev 16:2916:29, 4 December 2023‎ Francine talk contribs‎ 90,609 bytes +90,609‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Humanitas Research Hospital page '''NCTID''': NCT04800497 '''Title''': The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC '''Study Summary''': Hepatocellular carcinoma (HCC) recurs in up to 60% of patients who undergo resection. Circulating tumor cells (CTC) have been advocated as promotors of the recurrence. However, their role as prognostic markers in the surgic..."